EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Enveric Biosciences's enterprise value is $-0.95 Mil.
Enveric Biosciences's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00 Mil. Therefore, Enveric Biosciences's EV-to-Revenue for today is .
The historical rank and industry rank for Enveric Biosciences's EV-to-Revenue or its related term are showing as below:
During the past 13 years, the highest EV-to-Revenue of Enveric Biosciences was 21.07. The lowest was -0.15. And the median was 0.64.
ENVB's EV-to-Revenue is not ranked *
in the Biotechnology industry.
Industry Median: 8.205 * Ranked among companies with meaningful EV-to-Revenue only.
The historical data trend for Enveric Biosciences's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Enveric Biosciences's EV-to-Revenue
For the Biotechnology subindustry, Enveric Biosciences's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Enveric Biosciences's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Enveric Biosciences's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Enveric Biosciences's EV-to-Revenue falls into.
Enveric Biosciences's current Enterprise Value is $-0.95 Mil.
Enveric Biosciences's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enveric Biosciences's share price for today is $0.84.
Enveric Biosciences's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enveric Biosciences EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Enveric Biosciences's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Enveric Biosciences (Enveric Biosciences) Business Description
Enveric Biosciences Inc is a patient-centric biotechnology company focused on developing new-generation, naturally occurring chemical compounds, such as cannabinoids to improve the lives of those who are adversely affected by the side effects of cancer treatments. Its product in the pipeline includes Glioblastoma Multiforme (GBM); Radiation Dermatitis and Chemotherapy-Induced Peripheral Neuropathy (CIPN).
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ENVB has been successfully added to your 